Drugs / BioBlock
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05552950 | May 2022 → Jul 2023 | COVID-19 | Chemi-Pharm AS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioBlock | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05552950 ↗ |
| Route | Intranasal | “BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray” NCT05552950 ↗ |